Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Corticosteroid Carpal Tunnel Treatment Less Effective Than Surgery

By HospiMedica staff writers
Posted on 19 Nov 2007
Surgery may be a better long-term treatment option than local injections of corticosteroids when treating naïve carpal tunnel syndrome (CTS), claims a new study.

Researchers at the Gandhi Health Center (IMSALUD 4th Area, Madrid, Spain) assessed the long-term outcomes of both surgery and corticosteroid injections in an observational extension of patients who were originally enrolled in an open, randomized, clinical trial comparing injection to surgery. More...
After the clinical trial, participants received the usual medical treatment for CTS, according to their doctors' opinions. Researchers noted whether participants needed any follow-up treatment. Therapeutic failure was defined as the need of any new therapeutic intervention on the affected wrist.

After an average follow-up of 5.9 years, 41.8% of participants who received corticosteroid injections needed additional treatment, while only 11.6% of participants who underwent surgery needed additional treatment. The researchers concluded that in long-term follow-up, decompression surgery is more effective than local injection with corticosteroids in naive CTS. The study was presented at the American College of Rheumatology annual scientific meeting, held during November 2007 in Boston (MA, USA).

"Local corticosteroid injections and decompression surgery are both equally effective in the treatment of naive carpal tunnel syndrome in the 1 year follow-up,” said lead author Domingo Ly-Pen, M.D., Ph.D. "Although almost half of the patients initially injected do not need any more treatment in the long-term, a little more than half will. Therefore, surgery appears to be more effective than injections in the long-term.”

Carpal tunnel syndrome is a common nerve disorder caused by compression of the median nerve as it passes through the carpal tunnel, located at the wrist on the palm side of the hand. When the median nerve is compressed, nerve impulses are slowed or blocked, resulting in symptoms ranging from mild occasional numbness to hand weakness, loss of feeling, and even loss of hand function.


Related Links:
Gandhi Health Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.